Fluorinated poly(propylenimine) dendrimers as gene vectors.
暂无分享,去创建一个
Yu Wang | Yiyun Cheng | Yu Wang | Mingming Wang | Jianru Xiao | Yiyun Cheng | Hongmei Liu | Hongmei Liu | Mingming Wang | Jianru Xiao
[1] Rongqin Huang,et al. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. , 2011, Biomaterials.
[2] Chen Jiang,et al. Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. , 2011, Biomaterials.
[3] R. Kannan,et al. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. , 2010, Drug discovery today.
[4] D. Tomalia. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry , 2005 .
[5] E. Laurini,et al. Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing. , 2013, Molecular pharmaceutics.
[6] K. Ryan,et al. Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system. , 2012, Biomaterials.
[7] M. Ogris,et al. Oligoethylenimine-grafted polypropylenimine dendrimers as degradable and biocompatible synthetic vectors for gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[8] Rongqin Huang,et al. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration. , 2011, Biomaterials.
[9] M. Breunig,et al. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery , 2007, Proceedings of the National Academy of Sciences.
[10] T. Minko,et al. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[11] W. Hennink,et al. Polymers for gene delivery: Charged for success. , 2011, Nature materials.
[12] Jong-sang Park,et al. Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. , 2007, Biomaterials.
[13] C. Liu,et al. Structurally flexible triethanolamine-core poly(amidoamine) dendrimers as effective nanovectors to deliver RNAi-based therapeutics. , 2014, Biotechnology advances.
[14] Daniel Anderson,et al. Delivery materials for siRNA therapeutics. , 2013, Nature materials.
[15] Donald A Tomalia,et al. Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.
[16] Chen Jiang,et al. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. , 2009, Biomaterials.
[17] L. Tziveleka,et al. Synthesis and characterization of guanidinylated poly(propylene imine) dendrimers as gene transfection agents. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[18] Zhaozhong Jiang,et al. Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. , 2011, Nature materials.
[19] Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers. , 2013, Angewandte Chemie.
[20] Hongmei Wu,et al. Serum tolerance and endosomal escape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives. , 2012, Biomaterials.
[21] D. Tomalia,et al. CommentaryDendrimers in biomedical applications—reflections on the field☆☆☆ , 2012 .
[22] Rui Guo,et al. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. , 2012, Biomaterials.
[23] Clive J Roberts,et al. Preferential liver gene expression with polypropylenimine dendrimers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[24] Jiahai Zhang,et al. Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity , 2011, International journal of nanomedicine.
[25] G. Vassaux,et al. Cancer-specific transgene expression mediated by systemic injection of nanoparticles. , 2009, Cancer research.
[26] A. Schätzlein,et al. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. , 2005, Cancer research.
[27] D. Stolz,et al. Bifunctional compounds for targeted hepatic gene delivery , 2007, Gene Therapy.
[28] Chen Jiang,et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. , 2009, Biomaterials.
[29] Laurence Tetley,et al. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[30] Jong-sang Park,et al. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[31] Mingming Wang,et al. A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios , 2014, Nature Communications.
[32] D. Tomalia. Interview: An architectural journey: from trees, dendrons/dendrimers to nanomedicine. Interview by Hannah Stanwix. , 2012, Nanomedicine.
[33] L. Tetley,et al. Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[34] Franz Josef Gildehaus,et al. Targeted Radioiodine Therapy of Neuroblastoma Tumors following Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene , 2009, Clinical Cancer Research.
[35] Wenjun Yang,et al. Disulfide cross-linked low generation dendrimers with high gene transfection efficacy, low cytotoxicity, and low cost. , 2012, Journal of the American Chemical Society.
[36] E. Wagner. Strategies to Improve DNA Polyplexes for in Vivo Gene Transfer: Will “Artificial Viruses” Be the Answer? , 2004, Pharmaceutical Research.
[37] Huixin He,et al. Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes. , 2010, ACS nano.
[38] Rui Peng,et al. Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfection. , 2011, Molecular pharmaceutics.
[39] Meng Zheng,et al. Non-viral gene transfection in vitro using endosomal pH-sensitive reversibly hydrophobilized polyethylenimine. , 2011, Biomaterials.
[40] Sabrina Pricl,et al. Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer. , 2012, Molecular pharmaceutics.
[41] Brett A. Helms,et al. Dendrimers at Work , 2006, Science.
[42] L. Tetley,et al. Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex. , 2011, Biomaterials.
[43] A. Schätzlein,et al. Dendrimers in gene delivery. , 2005, Advanced drug delivery reviews.
[44] D. Tomalia. Dendritic effects: dependency of dendritic nano-periodic property patterns on critical nanoscale design parameters (CNDPs) , 2012 .